Literature DB >> 8484481

Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.

P Schulz1, J Bujía, A Holly, V Shilling, E Kastenbauer.   

Abstract

INTRODUCTION: Transforming growth factor alpha (TGF-alpha) is known to be produced by normal human keratinocytes and to stimulate their proliferation. The squamous epithelium of middle ear cholesteatoma is believed to exhibit hyperproliferative characteristics. This study was undertaken to determine if growth factors can be identified in cholesteatoma.
MATERIALS AND METHODS: Cholesteatoma samples (n = 6) and retroauricular skin (n = 9) were obtained during surgery. Monoclonal antibody against epidermal growth factor (EGF) and TGF-alpha were evaluated in these specimens using immunohistochemical techniques.
RESULTS: Epidermal growth factor receptor (EGF-R) was highly expressed in the basal layer of the epidermis, hair follicles, eccrine sweat glands, and the capillary system of normal skin. In the majority of cholesteatoma samples, expression of EGF-R was not confined to the basal layer but persisted in suprabasal cells of the stratum spinosum and stratum granulosum. In two cases, heterogenous standing was found in different parts of the same cryosection. Staining for TGF-alpha was consistently stronger in cholesteatoma than in normal skin, and encompassed all epithelial cell layers. Immune cells infiltrating the stroma of cholesteatoma stained positively for TGF-alpha.
CONCLUSION: These data are consistent with autocrine stimulation of the squamous epithelium of cholesteatoma by TGF-alpha contributing to its unrestrained growth in the middle ear cavity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8484481     DOI: 10.1016/0196-0709(93)90044-8

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  10 in total

1.  Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.

Authors:  J Bujia; H Sudhoff; A Holly; H Hildmann; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.

Authors:  J Bujía; C Kim; P Ostos; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

3.  EGFR expression in acquired middle ear cholesteatoma in children and adults.

Authors:  Adriana Leal Alves; Celina Siqueira Barbosa Pereira; Maria de Fatima Pereira Carvalho; Jose Humberto Tavares Guerreiro Fregnani; Fernando Quintanilha Ribeiro
Journal:  Eur J Pediatr       Date:  2011-07-29       Impact factor: 3.183

4.  In vivo over-expression of KGF mimic human middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Naotaro Akiyama; Yasuaki Shibata; Haruo Takahashi; Tohru Ikeda; Takehiko Koji
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-20       Impact factor: 2.503

5.  Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.

Authors:  A Holly; M Sittinger; J Bujia
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

6.  Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity.

Authors:  Tomomi Yamamoto-Fukuda; Mariko Terakado; Yoshitaka Hishikawa; Takehiko Koji; Haruo Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-02       Impact factor: 2.503

7.  Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity.

Authors:  J Bujía; C Kim; P Ostos; H Sudhoff; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

8.  Establishment and characterization of an in vitro model for cholesteatoma.

Authors:  Alexander M Raynov; Yun-Hoon Choung; Hun Yi Park; Seong Jun Choi; Keehyun Park
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-06-20       Impact factor: 3.372

Review 9.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

10.  Analysis of histopathological aspects in acquired middle ear cholesteatoma.

Authors:  Adriana Leal Alves; Celina Siqueira Barbosa Pereira; Fernando de Andrade Quintanilha Ribeiro; Jose Humberto Tavares Guerreiro Fregnani
Journal:  Braz J Otorhinolaryngol       Date:  2008 Nov-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.